‘Medicare for All’ vs. ‘Medicare for Less’?

The liberal talking point is inaccurate. But there’s a reason it resonates with the public. The 2020 presidential race will pit the Democrats’ “Medicare for All” proposal against the Trump administration’s “Medicare for Less.” At least that’s how the Washington Post and some Democratic political operatives suggest it will play out. According to the Post article, progressives are...

Trump Blames the Wrong Government for High Drug Prices

Medicare-for-All enthusiasts gaze wistfully at government-run health care systems abroad and see much to admire. When it comes to drug prices, the Trump administration seems to share that admiration. The Department of Health and Human Services is preparing to launch a massive demonstration program that would link Medicare reimbursement for physician-administered drugs to foreign prices. The...

Examination of International Drug Pricing Policies in Selected Countries Shows Prevalent Government Control over Pricing and Restrictions on Access

Report Extract: The Trump Administration has proposed using its demonstration authority under section 1115A of the Social Security Act to test a method of reimbursement for physician-administered drugs based on prices in 14 countries. The proposal is controversial, raising constitutional questions about the agency’s authority to modify Medicare reimbursement absent congressional action, as well...